Tonix Pharmaceuticals Announces Potential Positive Impact of the U.S. National Academies (NASEM) New Definition of Long COVID on the Size of the Fibromyalgia Market for Tonmya™

August 1, 2024

https://www.globenewswire.com/news-release/2024/07/31/2921797/28908/en/Tonix-Pharmaceuticals-Announces-Potential-Positive-Impact-of-the-U-S-National-Academies-NASEM-New-Definition-of-Long-COVID-on-the-Size-of-the-Fibromyalgia-Market-for-Tonmya.html

Fibromyalgia is a “diagnosable condition” in people suffering from Long COVID according to NASEM1

Diagnosing fibromyalgia in Long COVID patients is expected to expand the potential addressable market for Tonmya relative to pre-COVID-19 pandemic estimates2

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.